Status:

COMPLETED

Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis

Lead Sponsor:

The Cleveland Clinic

Collaborating Sponsors:

GE Healthcare

Conditions:

Takayasu's Arteritis

Giant Cell Arteritis

Eligibility:

All Genders

18-100 years

Brief Summary

The purpose of this study is to evaluate the ability of contrast enhanced carotid ultrasound to serve as an indicator of disease activity in patients with Takayasu's arteritis or Giant Cell arteritis ...

Detailed Description

Takayasu's arteritis and Giant Cell arteritis are chronic, relapsing diseases of the large arteries which can lead to significant narrowing of the arteries through episodes of inflammation within the ...

Eligibility Criteria

Inclusion

  • Male and female patients \>18 years
  • Diagnosis of Takayasu's arteritis or giant cell arteritis
  • Suspicion of common carotid involvement on the basis of physical examination (cervical bruit), carotidynia, documented CCA involvement on an imaging study (MRA, CTA, or ultrasound), or documented upper extremity large vessel involvement on an imaging study (MRA or CTA or ultrasound).
  • Ability to provide informed consent

Exclusion

  • Prior stroke, carotid surgery or angioplasty
  • Pregnant (or trying to become pregnant)
  • Nursing
  • Known or suspected cardiac shunt
  • Documented hypersensitivity to the contrast agent
  • Severe pulmonary hypertension or unstable cardiopulmonary conditions (acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, serious ventricular arrhythmias, or respiratory failure)

Key Trial Info

Start Date :

August 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT01795456

Start Date

August 1 2010

End Date

January 1 2014

Last Update

January 27 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic Main Campus, Section of Vascular Medicine

Cleveland, Ohio, United States, 44011